To investigate alterations in deep retinal vascular complex (DVC) in patients with non-neovascular intermediate AMD (iAMD), treatment-naïve quiescent macular neovascularization (qMNV), exudative AMD (eAMD) by means of OCT angiography (OCTA).
Methods:
Patients with iAMD, qMNV, eAMD and healthy controls presenting in the Department of Ophthalmology of the Centre Hospitalier Intercommunal de Créteil between January 2016 and January 2018, were retrospectively included. 3 × 3-mm OCTA (AngioVue RTVue XR Avanti) perfusion density (PD) of DVC was computed in all groups at baseline and follow up (12.0 ± 1.1 months).
Results:
A total of 46 eyes of 45 patients were enrolled: 11/46 iAMD, 10/46 qMNV, 13/46 eAMD, 12/46 control eyes. PD showed a significant decrease during follow-up in qMNV (p = 0.0059) and iAMD (p = 0.0076) eyes. PD in eAMD and healthy controls didn’t show significant changes.
Conclusion:
PD decreases at the level of DVC in eyes with qMNV and iAMD, while in eAMD eyes, PD is stable throughout follow up, suggesting that repeated anti-vascular endothelial growth factor (VEGF) injections do not impact on the DVC PD.
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology2000; 107(12): 2224–2232.
2.
ColemanHRChanCCFerrisFLIII, et al. Age-related macular degeneration. Lancet2008; 372(9652): 1835–1845.
3.
MaJDesaiRNesperP, et al. Optical coherence tomographic angiography imaging in age-related macular degeneration. Ophthalmol Eye Dis2017; 9: 1179172116686075.
4.
QuerquesGSrourMMassambaN, et al. Functional characterization and multimodal imaging of treatment-naive “quiescent” choroidal neovascularization. Invest Ophthalmol Vis Sci2013; 54(10): 6886–6892.
5.
CarnevaliACicinelliMVCapuanoV, et al. Optical coherence tomography angiography: a useful tool for diagnosis of treatment-naive quiescent choroidal neovascularization. Am J Ophthalmol2016; 169: 189–198.
6.
SpaideRFKlancnikJMJrCooneyMJ.Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol2015; 133(1): 45–50.
7.
CoscasFSellamAGlacet-BernardA, et al. Normative data for vascular density in superficial and deep capillary plexuses of healthy adults assessed by optical coherence tomography angiography. Invest Ophthalmol Vis Sci2016; 57(9): Oct211– Oct223.
8.
Vo KimSSemounOPedinielliA, et al. Optical coherence tomography angiography quantitative assessment of exercise-induced variations in retinal vascular plexa of healthy subjects. Invest Ophthalmol Vis Sci2019; 60(5): 1412–1419.
9.
BorrelliETotoLViggianoP, et al. Widefield topographical analysis of the retinal perfusion and neuroretinal thickness in healthy eyes: a pilot study. Eye. Epub ahead of print February2020. DOI: 10.1038/s41433-020-0804-5.
10.
BorrelliEAbdelfattahNSUjiA, et al. Postreceptor neuronal loss in intermediate age-related macular degeneration. Am J Ophthalmol2017; 181: 1–11.
11.
RamkumarHLNguyenBBartschDU, et al. Reduced ganglion cell volume on optical coherence tomography in patients with geographic atrophy. Retina2018; 38(11): 2159–2167.
12.
LeeSCTranSAminA, et al. Retinal vessel density in exudative and non-exudative age-related macular degeneration on optical coherence tomography angiography. Am J Ophthalmol2020; 212: 7–16.
13.
Garcia-LayanaACabrera-LopezFGarcia-ArumiJ, et al. Early and intermediate age-related macular degeneration: update and clinical review. Clin Interv Aging2017; 12: 1579–1587.
14.
FerrisFLIIIWilkinsonCPBirdA, et al. Clinical classification of age-related macular degeneration. Ophthalmology2013; 120(4): 844–851.
15.
JiaYMorrisonJCTokayerJ, et al. Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express2012; 3(12): 3127–3137.
16.
TotoLBorrelliEDi AntonioL, et al. Retinal vascular plexuses’ changes in dry age-related macular degeneration, evaluated by means of optical coherence tomography angiography. Retina2016; 36(8): 1566–1572.
17.
GranitR.The components of the retinal action potential in mammals and their relation to the discharge in the optic nerve. J Physiol1933; 77(3): 207–239.
18.
FeiglB.Age-related maculopathy - linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res2009; 28(1): 63–86.
19.
Wangsa-WirawanNDLinsenmeierRA.Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol2003; 121(4): 547–557.
20.
LeeEKYuHG.Ganglion cell-inner plexiform layer and peripapillary retinal nerve fiber layer thicknesses in age-related macular degeneration. Invest Ophthalmol Vis Sci2015; 56(6): 3976–3983.
21.
YouQSWangJGuoY, et al. Detection of reduced retinal vessel density in eyes with geographic atrophy secondary to age-related macular degeneration using projection-resolved optical coherence tomography angiography. Am J Ophthalmol2020; 209: 206–212.
22.
HikichiTAgarieM.Reduced vessel density of the choriocapillaris during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci2019; 60(4): 1088–1095.
23.
CampochiaroPAWykoffCCShapiroH, et al. Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. Ophthalmology2014; 121(9): 1783–1789.
24.
CampochiaroPABhisitkulRBShapiroH, et al. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology2013; 120(4): 795–802.
25.
Vo KimSFajnkuchenFSardaV, et al. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting. Graefes Arch Clin Exp Ophthalmol2017; 255(11): 2165–2171.
26.
BarashAChuiTYPGarciaP, et al. Acute macular and peripapillary angiographic changes with intravitreal injections. Retina2020; 40(4): 648–656.
27.
Ghasemi FalavarjaniKIafeNAHubschmanJP, et al. Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-vegf therapy in eyes with diabetic macular edema and retinal vein occlusion. Invest Ophthalmol Vis Sci2017; 58(1): 30–34.
